Administration on Intellectual and Developmental Disabilities, President's Committee for People With Intellectual Disabilities, 38448-38449 [2015-16488]

Download as PDF 38448 Federal Register / Vol. 80, No. 128 / Monday, July 6, 2015 / Notices 1. Home Bancorp, Inc., Lafayette, Louisiana; to acquire Louisiana Bancorp, Inc., Metairie, Louisiana, and indirectly acquire Bank of New Orleans, Metairie, Louisiana, a federal savings association, and thereby engage in operating a savings association, pursuant to section 225.28(b)(4)(ii). Board of Governors of the Federal Reserve System, June 30, 2015. Michael J. Lewandowski, Associate Secretary of the Board. [FR Doc. 2015–16466 Filed 7–2–15; 8:45 am] BILLING CODE 6210–01–P DEPARTMENT OF HEALTH AND HUMAN SERVICES Administration for Community Living Agency Information Collection Activities; Proposed Collection; Comment Request; Extension of Certification of Maintenance of Effort on Help America Vote Act, Public Law 107–252, Title II, Subtitle D, Section 291, Payments for Protection and Advocacy Systems (P&A Voting Access Narrative Annual Report) Administration on Intellectual and Developmental Disabilities, Administration for Community Living, HHS. ACTION: Notice. AGENCY: The Administration for Community Living (ACL) is announcing that the proposed collection of information listed below has been submitted to the Office of Management and Budget (OMB) for review and clearance. Under the Paperwork Reduction Act of 1995 (the PRA), Federal agencies are required to publish notice in the Federal Register concerning each proposed collection of information, including each proposed extension of an existing collection of information, and to allow public comment in response to the notice. This notice solicits comments on the information collection requirements relating to the Help America Vote Act (HAVA), Public Law 107–252, Title II, Subtitle D, Section 291, Payments for Protection and Advocacy Systems (P&A Voting Access Narrative Annual Report). DATES: Submit written comments on the collection of information by August 5, 2015. ADDRESSES: Submit written comments on the collection of information by fax 202.395.5806 or by email to OIRA_ submission@omb.eop.gov, Attn: OMB Desk Officer for ACL. Lhorne on DSK7TPTVN1PROD with NOTICES SUMMARY: VerDate Sep<11>2014 14:37 Jul 02, 2015 Jkt 235001 FOR FURTHER INFORMATION CONTACT: Melvenia Wright, Program Specialist, Administration for Community Living, Washington, DC 20001. Telephone: (202) 357–3486; email melvenia.wright@ acl.hhs.gov. SUPPLEMENTARY INFORMATION: Under the PRA (44 U.S.C. 3501–3520), Federal agencies must obtain approval from the Office of Management and Budget (OMB) for each collection of information they conduct or sponsor. ‘‘Collection of information’’ is defined in 44 U.S.C. 3502(3) and 5 CFR 1320.3(c) and includes agency request or requirements that members of the public submit reports, keep records, or provide information to a third party. Section 3506(c)(2)(A) of the PRA (44 U.S.C. 3506(c)(2)(A)) requires Federal agencies to provide a 60-day notice in the Federal Register concerning each proposed collection of information, including each proposed extension of an existing collection of information, before submitting the collection to OMB for approval. To comply with this requirement, ACL is publishing notice of the proposed collection of information set forth in this document. With respect to the following collection of information, ACL invites comments on: (1) Whether the proposed collection of information is necessary for the proper performance of ACL’s functions, including whether the information will have practical utility; (2) the accuracy of ACL’s estimate of the burden of the proposed collection of information, including the validity of the methodology and assumptions used; (3) ways to enhance the quality, utility, and clarity of the information to be collected; and (4) ways to minimize the burden of the collection of information on respondents, including through the use of automated collection techniques when appropriate, and other forms of information technology. The Protection and Advocacy Voting Access Annual Narrative Report from the Protection and Advocacy Systems is required by federal statute and regulation, the Help America Vote Act (HAVA), Public Law 107–252, Title II, Subtitle D, Section 291, Payments for Protection and Advocacy to Assure Access for Individuals with Disabilities (42 U.S.C. 15461). The report is provided in writing to the Administration for Community Living, Administration on Intellectual and Developmental Disabilities (AIDD). Each eligible Protection and Advocacy System (P&As) must prepare and submit an annual report at the end of every fiscal year by the 31st of December. The report addresses the activities conducted with PO 00000 Frm 00022 Fmt 4703 Sfmt 4703 the funds provided during the year. The information collected from the annual report will be aggregated into an annual profile of how the P&As have utilized the funds and review the P&As activities carried out for each of the seven mandated area. These areas include full participation in the electoral process; education, training and assistance; advocacy and education around HAVA implementation efforts; training and education of election officials, poll workers and election volunteers regarding the rights of voters with disabilities and best practices; assistance in filing complaints; assistance to State and other governmental entities regarding the physical accessibility of polling places; and obtaining training and technical assistance on voting issues. The PAVA annual narrative report will also provide an overview of the goals and accomplishments for each P&A as well as permit the Administration on Intellectual and Developmental Disabilities (AIDD) to track voting progress to monitor grant activities and create the bi-annual report to Congress. ACL estimates the burden of this collection of information as follows: 55 Protection and Advocacy Systems (P&A) respond annually which should be an average burden of 20 hours per State per year or a total of 1,100 hours for all states annually. Dated: June 29, 2015. Kathy Greenlee, Administrator and Assistant Secretary for Aging. [FR Doc. 2015–16492 Filed 7–2–15; 8:45 am] BILLING CODE 4154–01–P DEPARTMENT OF HEALTH AND HUMAN SERVICES Administration for Community Living Administration on Intellectual and Developmental Disabilities, President’s Committee for People With Intellectual Disabilities Administration for Community Living, HHS. ACTION: Notice. AGENCY: Monday, August 3, 2015 from 9:00 a.m. to 4:30 p.m.; and Tuesday, August 4, 2015 from 9:30 a.m. to 4:00 p.m. These meetings will be open to the general public. ADDRESSES: These meetings will be held in the U.S. Department of Health and Human Services/Hubert H. Humphrey Building located at 200 Independence Avenue SW., Conference Room 800, Washington, DC 20201. DATES: E:\FR\FM\06JYN1.SGM 06JYN1 Federal Register / Vol. 80, No. 128 / Monday, July 6, 2015 / Notices Individuals who would like to participate via conference call may do so by dialing toll-free 888–469–0957, when prompted enter pass code: 8955387. Individuals whose full participation in the meeting will require special accommodations (e.g., sign language interpreting services, assistive listening devices, materials in alternative format such as large print or Braille) should notify Dr. MJ Karimi, PCPID Team Lead, via email at MJ.Karimie@acl.hhs.gov, or via telephone at 202–357–3588, no later than Monday, July 27, 2015. The PCPID will attempt to accommodate requests made after this date, but cannot guarantee the ability to grant requests received after the deadline. All meeting sites are barrier free, consistent with the Americans with Disabilities Act (ADA) and the Federal Advisory Committee Act (FACA). Agenda: The Committee Members will discuss, finalize and approve the 2015 PCPID Report to the President. They will also begin exploring the topics for the next PCPID Report to the President. FOR FURTHER INFORMATION CONTACT: For further information, please contact Dr. MJ Karimi, Team Lead, President’s Committee for People with Intellectual Disabilities, One Massachusetts Avenue NW., Room 4206, Washington, DC 20201. Telephone: 202–357–3588. Fax: 202–205–8037. Email: MJ.Karimie@ acl.hhs.gov The PCPID acts in an advisory capacity to the President and the Secretary of Health and Human Services on a broad range of topics relating to programs, services and support for individuals with intellectual disabilities. The PCPID executive order stipulates that the Committee shall: (1) Provide such advice concerning intellectual disabilities as the President or the Secretary of Health and Human Services may request; and (2) provide advice to the President concerning the following for people with intellectual disabilities: (A) expansion of educational opportunities; (B) promotion of homeownership; (C) assurance of workplace integration; (D) improvement of transportation options; (E) expansion of full access to community living; and (F) increasing access to assistive and universally designed technologies. Lhorne on DSK7TPTVN1PROD with NOTICES SUPPLEMENTARY INFORMATION: Dated: June 24, 2015. Aaron Bishop, Commissioner, Administration on Intellectual and Developmental Disabilities (AIDD). [FR Doc. 2015–16488 Filed 7–2–15; 8:45 am] BILLING CODE 4154–01–P VerDate Sep<11>2014 14:37 Jul 02, 2015 Jkt 235001 DEPARTMENT OF HEALTH AND HUMAN SERVICES Food and Drug Administration [Docket No. FDA–2015–D–2270] The Drug Supply Chain Security Act Implementation: Product Tracing Requirements for Dispensers— Compliance Policy; Guidance for Industry, Availability AGENCY: Food and Drug Administration, HHS. ACTION: Notice. The Food and Drug Administration (FDA or we) is announcing the availability of a guidance for industry entitled ‘‘DSCSA Implementation: Product Tracing Requirements for Dispensers— Compliance Policy.’’ This guidance announces FDA’s intention with regard to enforcement of certain product tracing requirements of the Federal Food, Drug, and Cosmetic Act (FD&C Act) added by the Drug Supply Chain Security Act (DSCSA). FDA does not intend to take action against dispensers who, prior to November 1, 2015, accept ownership of product without receiving product tracing information, prior to or at the time of a transaction or do not capture and maintain the product tracing information, as required by the FD&C Act. DATES: Effective July 1, 2015. For information about enforcement dates, please see the SUPPLEMENTARY INFORMATION section. ADDRESSES: All communications in response to this notice should be identified with Docket No. FDA–2015– D–2270, and should be directed to the office listed in the FOR FURTHER INFORMATION CONTACT section. FOR FURTHER INFORMATION CONTACT: Office of Compliance, Center for Drug Evaluation and Research, Food and Drug Administration, 10903 New Hampshire Ave., Silver Spring, MD 20993–0002, 301–796–3130, drugtrackandtrace@fda.hhs.gov. SUPPLEMENTARY INFORMATION: SUMMARY: I. Background We are announcing the availability of a guidance for industry entitled ‘‘DSCSA Implementation: Product Tracing Requirements for Dispensers— Compliance Policy.’’ We are issuing this guidance consistent with our good guidance practices regulation (21 CFR 10.115). We are implementing this guidance without prior public comment because we have determined that prior public participation is not feasible or PO 00000 Frm 00023 Fmt 4703 Sfmt 4703 38449 appropriate (21 CFR 10.115(g)(2)). We made this determination because this guidance document provides information pertaining to statutory requirements that take effect on July 1, 2015, regarding the provisions to provide and capture product tracing information under section 582(d)(1) of the FD&C Act (21 U.S.C 360eee–1(d)(1)). It is important that FDA provide this information before that date. Although this guidance document is immediately in effect, it remains subject to comment in accordance with the Agency’s good guidance practices (21 CFR 10.115(g)(3)). On November 27, 2013, the DSCSA (Title II of Pub. L. 113–54) was signed into law. Section 202 of DSCSA adds sections 581 and 582 to the FD&C Act, which set forth new definitions and requirements for the tracing of products through the pharmaceutical distribution supply chain. Starting in 2015, trading partners (manufacturers, wholesale distributors, dispensers, and repackagers) are required under sections 582(b)(1), (c)(1), (d)(1), and (e)(1) of the FD&C Act to exchange product tracing information when engaging in transactions involving certain prescription drugs. For dispensers, requirements for the tracing of products through the pharmaceutical distribution supply chain under section 582(d)(1) of the FD&C Act go into effect on July 1, 2015. Some dispensers have expressed concern that electronic systems used to exchange, capture, and maintain product tracing information will not be operational by this effective date. Although the DSCSA allows product tracing information to be exchanged through paper in certain circumstances, FDA understands that many dispensers intend to utilize electronic systems to capture and maintain product tracing information. Thus, FDA recognizes that some dispensers may need additional time beyond July 1, 2015, to work with trading partners to ensure that the product tracing information required by section 582 is captured and maintained by dispensers. In light of these concerns, FDA does not intend to take action against dispensers who, prior to November 1, 2015: (1) Accept ownership of product without receiving product tracing information, prior to or at the time of a transaction, as required by section 582(d)(1)(A)(i) of the FD&C Act or (2) do not capture and maintain the product tracing information, as required by section 582(d)(1)(A)(iii) of the FD&C Act. This compliance policy does not extend to other requirements of the FD&C Act applicable to dispensers and other trading partners, including E:\FR\FM\06JYN1.SGM 06JYN1

Agencies

DEPARTMENT OF HEALTH AND HUMAN SERVICES
Administration for Community Living

[Federal Register Volume 80, Number 128 (Monday, July 6, 2015)]
[Notices]
[Pages 38448-38449]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2015-16488]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Administration for Community Living


Administration on Intellectual and Developmental Disabilities, 
President's Committee for People With Intellectual Disabilities

AGENCY: Administration for Community Living, HHS.

ACTION: Notice.

-----------------------------------------------------------------------

DATES: Monday, August 3, 2015 from 9:00 a.m. to 4:30 p.m.; and Tuesday, 
August 4, 2015 from 9:30 a.m. to 4:00 p.m. These meetings will be open 
to the general public.

ADDRESSES: These meetings will be held in the U.S. Department of Health 
and Human Services/Hubert H. Humphrey Building located at 200 
Independence Avenue SW., Conference Room 800, Washington, DC 20201.

[[Page 38449]]

    Individuals who would like to participate via conference call may 
do so by dialing toll-free 888-469-0957, when prompted enter pass code: 
8955387. Individuals whose full participation in the meeting will 
require special accommodations (e.g., sign language interpreting 
services, assistive listening devices, materials in alternative format 
such as large print or Braille) should notify Dr. MJ Karimi, PCPID Team 
Lead, via email at MJ.Karimie@acl.hhs.gov, or via telephone at 202-357-
3588, no later than Monday, July 27, 2015. The PCPID will attempt to 
accommodate requests made after this date, but cannot guarantee the 
ability to grant requests received after the deadline. All meeting 
sites are barrier free, consistent with the Americans with Disabilities 
Act (ADA) and the Federal Advisory Committee Act (FACA).
    Agenda: The Committee Members will discuss, finalize and approve 
the 2015 PCPID Report to the President. They will also begin exploring 
the topics for the next PCPID Report to the President.

FOR FURTHER INFORMATION CONTACT: For further information, please 
contact Dr. MJ Karimi, Team Lead, President's Committee for People with 
Intellectual Disabilities, One Massachusetts Avenue NW., Room 4206, 
Washington, DC 20201. Telephone: 202-357-3588. Fax: 202-205-8037. 
Email: MJ.Karimie@acl.hhs.gov

SUPPLEMENTARY INFORMATION: The PCPID acts in an advisory capacity to 
the President and the Secretary of Health and Human Services on a broad 
range of topics relating to programs, services and support for 
individuals with intellectual disabilities. The PCPID executive order 
stipulates that the Committee shall: (1) Provide such advice concerning 
intellectual disabilities as the President or the Secretary of Health 
and Human Services may request; and (2) provide advice to the President 
concerning the following for people with intellectual disabilities: (A) 
expansion of educational opportunities; (B) promotion of homeownership; 
(C) assurance of workplace integration; (D) improvement of 
transportation options; (E) expansion of full access to community 
living; and (F) increasing access to assistive and universally designed 
technologies.

    Dated: June 24, 2015.
Aaron Bishop,
Commissioner, Administration on Intellectual and Developmental 
Disabilities (AIDD).
[FR Doc. 2015-16488 Filed 7-2-15; 8:45 am]
 BILLING CODE 4154-01-P

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.